“…Mean blood flow through the PALP was 0.645 l/min and sweep gas flow was 8 l/min. RV-arterial coupling assessed by the ratio of Ees on Ea was improved [ 38 ]. Figure 3 Effects of PALP (‘Pump Assisted Lung Protection’, Maquet, Germany) therapy on systolic pulmonary artery pressure (PAP) in an experimental model of acute respiratory distress syndrome (ARDS).…”
Section: Rationale For the Use Of Ecco
2
R In Ardsmentioning
This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2015 and co-published as a series in Critical Care. Other articles in the series can be found online at http://ccforum.com/series/annualupdate2015. Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://www.springer.com/series/8901.
“…Mean blood flow through the PALP was 0.645 l/min and sweep gas flow was 8 l/min. RV-arterial coupling assessed by the ratio of Ees on Ea was improved [ 38 ]. Figure 3 Effects of PALP (‘Pump Assisted Lung Protection’, Maquet, Germany) therapy on systolic pulmonary artery pressure (PAP) in an experimental model of acute respiratory distress syndrome (ARDS).…”
Section: Rationale For the Use Of Ecco
2
R In Ardsmentioning
This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2015 and co-published as a series in Critical Care. Other articles in the series can be found online at http://ccforum.com/series/annualupdate2015. Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://www.springer.com/series/8901.
“…Mean blood flow through the PALP was 0.645 l/min and sweep gas flow was 8 l/min. RV-arterial coupling assessed by the ratio of Ees on Ea was improved [38].…”
This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2015 and co-published as a series in Critical Care. Other articles in the series can be found online at
ECCOR may be a promising adjuvant therapeutic strategy for the management of patients with severe exacerbations of COPD and for the achievement of protective or ultra-protective ventilation in patients with ARDS without life-threatening hypoxemia. Given the observational nature of most of the available clinical data and differences in technical features and performances of current devices, the balance of risks and benefits for or against ECCOR in such patient populations remains unclear CONCLUSIONS: ECCOR is currently an experimental technique rather than an accepted therapeutic strategy in ARF-its safety and efficacy require confirmation in clinical trials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
